David S. Grayzel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Eric Bell, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David S. Grayzel

Form 4 holding Director

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,784,730
Estimated value
$50,240,150
Report date
09 Apr 2024
Price
$28.15
Ownership
By Atlas Venture Fund XII, L.P.
Form 4 holding Director

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
14,502
Estimated value
$408,231
Report date
09 Apr 2024
Price
$28.15
Ownership
By Atlas Venture Associates XII, L.P.
Form 4 holding Director

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
$204,625
Report date
05 Jun 2024
Price
$16.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Q32 Bio Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,363
Estimated value
$44,998
Report date
15 Jan 2026
Price
$2.75
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surface Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
08 Sep 2023
Price
$0.9400
Ownership
Indirect

Insider Reports Filed by David S. Grayzel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .